Bart J. Van Der Auwera
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients.
Journal: Clinical and experimental immunology
Published: October 06, 2022
Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.
Journal: BMC endocrine disorders
Published: August 29, 2021
Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens.
Journal: Virchows Archiv : an international journal of pathology
Published: November 19, 2020
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.
Journal: European journal of endocrinology
Published: April 17, 2019
Accelerated Progression to Type 1 Diabetes in the Presence of HLA-A*24 and -B*18 Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct HLA-DQ and Autoantibody Risk Profiles.
Journal: Diabetes care
Published: November 27, 2017
HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft.
Journal: Diabetes care
Published: December 21, 2015
HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.
Journal: Diabetes
Published: November 20, 2012
Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon.
Journal: Diabetes research and clinical practice
Published: September 04, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026